MOROCTOCOG ALFA for Factor viii deficiency: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 42 adverse event reports in the FDA FAERS database where MOROCTOCOG ALFA was used for Factor viii deficiency.
Most Reported Side Effects for MOROCTOCOG ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Joint swelling | 22 | 19.0% | 1 | 12 |
| Arthralgia | 21 | 18.1% | 1 | 12 |
| Off label use | 16 | 13.8% | 0 | 8 |
| Haemarthrosis | 15 | 12.9% | 0 | 5 |
| Haemorrhage | 15 | 12.9% | 1 | 5 |
| Joint range of motion decreased | 8 | 6.9% | 0 | 7 |
| Contusion | 7 | 6.0% | 0 | 2 |
| Haemophilic arthropathy | 7 | 6.0% | 0 | 5 |
| Ecchymosis | 6 | 5.2% | 0 | 5 |
| Drug ineffective | 5 | 4.3% | 0 | 2 |
| Mobility decreased | 5 | 4.3% | 0 | 5 |
| Peripheral swelling | 5 | 4.3% | 0 | 4 |
Other Indications for MOROCTOCOG ALFA
Other Drugs Used for Factor viii deficiency
EMICIZUMAB-KXWH (6,532)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (4,268)
EFMOROCTOCOG ALFA (832)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (722)
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (352)
ANTI-INHIBITOR COAGULANT COMPLEX (317)
EMICIZUMAB (315)
DAMOCTOCOG ALFA PEGOL (310)
EFANESOCTOCOG ALFA (292)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (180)